Vasculitis is inflammation of a vessel wall. The systemic and a major break was made in the 1990s with the 1990 American College of Rheumatology criteria (ACR 1990 vasculitides represent a highly heterogeneous group of clinicopathological entities. Vasculitis has many causes, criteria); and the elaboration of a uniform terminology for naming, defining, classifying and diagnosing vascualthough it produces only a few histological patterns of vascular inflammation. The clinical expression depends litic disorders at the Chapel Hill Conference 1992 (1992 CHC definitions). The 1990 ACR criteria were reviewed on the site, type and size of vessels involved. Vessels of any type in any organ can be affected, which is reflected in 1996 by Hunder [3] . The 1992 CHC definitions now include immunodiagnostically significant markers [e.g. in the wide variety of signs and symptoms. Clinically the systemic vasculitides range from benign, locoregion-ANCA in Wegener's granulomatosis ( WG)] and immunohistological findings (e.g. IgA-dominant immune ally restricted processes (e.g. cutaneous leucocytoclastic angiitis) to systemic vasculitis leading to life-threatening deposits in Henoch-Schö nlein purpura) which are specific for certain diseases and were described by conditions [e.g. pulmonary renal syndrome in antineutrophil cytoplasmic antibody (ANCA)-associated vascuJennette et al. [4] . The major problem with previous classification schemes was the lack of standardized diaglitis]. Many patients develop their disease against a background of non-specific symptoms, such as malaise, nostic terms and definitions. As a consequence, different names had been applied to the same disease and the weight loss, fever and night sweats (so-called B-symptoms), which reflect constitutional symptoms.
same name to different diseases. Therefore, the CHC committee-comprised of internists, rheumatologists, More specific symptoms derive from the type of vessels involved; this has led to the well-known classification nephrologists, immunologists and pathologists who have in common extensive experience with diagnosing vascuscheme of primary systemic vasculitides ( Table 1) . However, in clinical practice vasculitic syndromes do litides-proposed the names and definitions given in Table 3 . not respect vessel size boundaries. In addition, discrete vasculitides with indistinguishable clinical presentations due to the predominant involvement of small vessels Immunopathogenesis have a very different prognosis and require different therapies. For example, a patient with purpura caused Most of the vasculitic syndromes are mediated by immunoby Henoch-Schö nlein purpura has a clearly better progpathogenic mechanisms ('immune vasculitides') and nosis and needs less aggressive therapy than a patient most 'immune vasculitides' are idiopathic (= 'primary' with purpura caused by microscopic polyangiitis vasculitis). The immunopathogenic mechanisms of vas-(MPA), which is likely to progress to life-threatening culitides have been classified into the four types of organ failure if not treated by immunosuppressives. So, hypersensitivity reaction described by Coombs and Gell in addition to the clinical picture, one needs to take into [35] ; this classification was reviewed recently [5] . account the histology and immune phenomena in the Accordingly, clinicopathological and immunohistoblood and tissues, and a broader differential diagnosis chemical studies have led to the terms allergic angiitis to avoid missing secondary vasculitides or vasculitis-like (I ), antibody-mediated angiitis, including the 'new' syndromes ( Table 2) .
group of ANCA-associated vasculitides (II ), immune complex vasculitis (III ), and vasculitis associated with T-cell-mediated hypersensitivity (IV ) ( eases with associated disorders).
The clinical utility of cANCA as a diagnostic marker supported by a recent analysis of ANCA results in a large routine laboratory (Regional Immunology for WG was recently confirmed in a large prospective European study undertaken with sera from vasculitis Laboratory, Belfast, UK ). The overall positive predictive value for primary systemic vasculitides was 38% for patients (sensitivity 60%, specificity 95%) [7] . However, when employed as a routine screening method for WG all cANCA and only 20% for all pANCA. Specificity improved when only antinuclear antibody (ANA)-(defined according to ACR criteria) in patients with suspected vasculitis, the sensitivity of cANCA in a recent negative samples with a high ANCA titre were considered (cANCA 90%, pANCA 60%) [10] . In most, but prospective single-centre study on 346 consecutive patients was only 28% (specificity for WG: 98%). The not all cases, titres correlated with disease activity. Rising titres should alert the clinician to an increased sensitivity rose to 83% if only biopsy-proven WG was considered [8] . A meta-analysis of 15 studies comprising risk of exacerbation, but are generally not regarded as an indication for intensifying therapy [11] . 13 652 patients (including 736 cases of WG) yielded a pooled sensitivity of 66% and a specificity of 98% [9] .
ELISAs are used to specify further the target antigens of ANCA, namely proteinase 3 (PR3; cANCA-positive Taken together, these data show that the value of cANCA testing is limited by a rather low sensitivity; the samples have a 99% specificity for WG) [7] , myeloperoxidase (MPO; 80% specificity for MPA) [7] , as well as greatest utility of cANCA testing may be in patients with suspected, but not yet proven, WG. This view is less important target antigens such as cathepsin G, Takayasu arteritis Granulomatous inflammation of the aorta and its major branches. Usually occurs in patients younger than 50 yr.
Medium-sized vessel vasculitisa
Polyarteritis nodosab (classic polyarteritis nodosa) Necrotizing inflammation of medium-sized or small arteries without glomerulonephritis or vasculitis in arterioles, capillaries, or venules.
Kawasaki disease
Arteritis involving large-, medium-sized, and small arteries, and associated with mucocutaneous lymph node syndrome.
Coronary arteries are often involved. Aorta and veins may be involved. Usually occurs in children.

Small vessel vasculitisa WGc
Granulomatous inflammation involving the respiratory tract, and necrotizing vasculitis affecting small-to medium-sized vessels (e.g. capillaries, venules, arterioles, and arteries). Necrotizing glomerulonephritis is common.
CSSc Eosinophil-rich and granulomatous inflammation involving the respiratory tract, and necrotizing vasculitis affecting smallto medium-sized vessels, and associated with asthma and eosinophilia.
MPAb,c (microscopic polyarteritis) Necrotizing vasculitis, with few or no immune deposits affecting small vessels (i.e. capillaries, venules, or arterioles).
Necrotizing arteritis involving small-and medium-sized arteries may be present. Necrotizing glomerulonephritis is very common. Pulmonary capillaritis often occurs.
Henoch-Schö nlein purpura Vasculitis, with IgA-dominant immune deposits, affecting small vessels (i.e. capillaries, venules, or arterioles). Typically involves skin, gut, and glomeruli, and is associated with arthralgias or arthritis.
Essential cryoglobulinaemic vasculitis Vasculitis, with cryoglobulin immune deposits, affecting small vessels (i.e. capillaries, venules, or arterioles), and associated with cryoglobulins in serum. Skin and glomeruli are often involved.
Cutaneous leucocytoclastic angiitis Isolated cutaneous leucocytoclastic angiitis without systemic vasculitis or glomerulonephritis.
aLarge vessel refers to the aorta and the largest branches directed towards major body regions (e.g. to the extremities and the head and neck); medium-sized vessel refers to the main visceral arteries (e.g. renal, hepatic, coronary, and mesenteric arteries); small vessel refers to venules, capillaries, arterioles, and the intraparenchymal distal arterial radicals that connect with arterioles. Some small and large vessel vasculitides may involve medium-sized arteries, but large-and medium-sized vessel vasculitides do not involve vessels smaller than arteries. Essential components are represented by normal type; italicized type represents usual, but not essential components.
bPreferred term. cStrongly associated with ANCA.
Reproduced from [4] lactoferrin, lysozyme and human leucocyte elastase, are completed, ANCA serology remains the most important tool in the diagnostic repertoire for ANCAwhich are not specific for any particular vasculitic disorder. Whether anti-bactericidal permeability increasing associated vasculitides, especially in seriously ill patients suspected of having vasculitis. Under life-threatening protein (BPI ) ANCA offer further diagnostic perspectives in vasculitis is still unclear [12] [13] [14] .
conditions, therefore, therapy should be commenced based on clinical and serological findings! An overview So, ANCA are not specific for ANCA-associated vasculitides and despite the high specificity of of predominant immune phenomena in systemic vasculitides associated with the hypersensitivity reaction types cANCA/PR3-ANCA for WG and of MPO-pANCA for MPA, an increasing number of 'false-positive' (and the serological markers) is given in Table 5 . The incidence of ANCA in CSS is much lower than in PR3-/MPO-ANCA have been described [11] . More recently, we and others have observed PR3-ANCA in WG and MPA, and their immunodiagnostic significance is limited [7] . However, active CSS is characterized by subacute bacterial endocarditis, a condition sometimes associated with vasculitis [15] . Still, because ANCA test increased eosinophils in conjunction with strongly elevated IgE and eosinophil cationic protein values [17] . results are usually available before histological analyses Furthermore, endothelial cell damage in active AAV tion of the disease, and determination of the disease activity and extent. The latter is all the more important is indicated by markedly increased serum thrombomodulin (sTM ) values [17] : in CSS, high levels of sTM as stage-adapted treatment and assessment of the treatment's efficacy are only possible if there are uniform correlate closely with the soluble interleukin-2 receptor, which has been shown to be a promising seromarker of and reproducible measures of the extent and activity of organ involvement in the vasculitic disease. A predisease activity in WG [18] .
Because intermittent infections are a major differential requisite for this is a standardized evaluation of the clinical, radiological and laboratory findings by an interdiagnostic problem in seriously ill AAV patients ( Table 6 ), a marker that distinguishes between the two disciplinary team of expert physicians (internal medicine, neurology, ophthalmology, dermatology, radiology, etc.). conditions is urgently needed. Procalcitonin was recently shown to be normal in active autoimmune rheumatic Semi-quantitative scoring systems were recently developed for the standardized assessment of disease disorders, but strongly elevated in concomitant bacterial infections and sepsis [19] . However, these findings have activity and extent. On the basis of the extended ( ENT, lung, kidney) ELK classification [21, 22] , a disease yet to be confirmed [20] . extent index (DEI ) was established by our group [23] . This instrument has been well accepted by German Diagnosis vasculitis centres because it can be easily and quickly applied pro-and retrospectively and is valid, reliable, A detailed patient history, physical examination and focused laboratory investigation are vital in diagnosing sensitive to change, and highly reproducible ( Table 7) . The DEI may also be of prognostic value in therapeutic vasculitic disorders. The goals of the work-up include identification of a cause of the disease and/or the trials. Pulse cyclophosphamide treatment, for example, proved to be less effective in patients with a DEI >7 at underlying immunopathogenetic mechanism, classifica- the start of treatment [23] . In addition, a vasculitis litic process, i.e. drugs, infections or neoplastic manifestations ( Table 8 ). This search must be carried out very activity score (Birmingham vasculitis activity score; BVAS ) has been developed, validated and computerized carefully with regard to the clinical investigation, starting with close examination of the patient's history and [25] . Because of its magnitude, the BVAS is used more often in clinical studies than in daily clinical practice.
environment. Then imaging procedures have to be carried out in order to determine the disease extent. Various Whether the two scores are complementary or could be substituted one for the other remains to be elucidated. laboratory markers will additionally reflect or accord with the clinical impression with respect to disease Laboratory tests should be used to ascertain the type of vasculitis, the organ systems affected, and the extent activity ( Table 5) . A biopsy should next be taken from a site of tissue involvement in order to avoid false of organ involvement. However, many of these tests are non-specific; the erythrocyte sedimentation rate ( ESR) and acute-phase proteins like C-reactive protein (CRP) small vessel vasculitides are given in Table 5 .
Infectious diseases
The definite diagnosis of systemic vasculitis, however, negative results, which is frequently the consequence of class I haplotypes by different patients may have an biopsies taken blind. After all, the question whether the influence on the spectrum of their clinical symptoms disease is really one of the group known collectively as and infections. Analysis of patients with defects in the primary systemic vasculitis, or a secondary form class I presentation pathway is therefore of importance ( Table 8) , or an infection-induced process, or something to understand the relationship between susceptibility to entirely new, must be answered. The increase in the infectious diseases, autoimmune disorders and HLA number of cases of vasculitis due to growing awareness, class I haplotype in an outbred population. better diagnostic tools, etc., has been accompanied by a
In the diagnosis of a patient with suspected vasculitis parallel increase in the number of vasculitic syndromes there are no agreed upon criteria for the various categorassociated with infections, immunodeficiencies, etc.
ies of vasculitis. It is noteworthy that the ACR 1990 Recently, granulomatous vasculitis affecting small cutacriteria were not designed for diagnosis. However, the neous blood vessels and purpura due to leucocytoclastic proposed names and definitions for vasculitic disorders vasculitis and associated with the herpes virus were proposed in the 1992 CHC definitions [4] are being observed [26, 27] . Moreover, a neurobrucellosis mimickincreasingly used for diagnosis. The diagnosis of vascuing cerebral vasculitis [28] and a WG-like syndrome litis requires the knowledgeable integration of clinical, were identified as a case of primary immunodeficiency histological (immunohistological ) and laboratory data. due to a defect of the MHC gene complex class I Chest and sinus radiographs by computed tomographic processing and presentation pathway [29] .
scans and/or nuclear magnetic resonance imaging First we reported a case of primary immunodeficiency may reveal occult respiratory tract disease [31, 32] . due to a defect of the transporter associated with antigen Confirmation that eyes, ears, nose or throat are involved presentation ( TAP) genes, a heterodimeric complex often requires the expertise of an ENT and/or ophthalwhich controls the expression of HLA class I molecules mology specialist [33] . In addition, nerve conduction by delivering peptides from the cytosol into the lumen studies can document the severity and progression (or of the endoplasmic reticulum. Since childhood, the regression) of peripheral neuropathy. 36-yr-old female suffered from recurrent sinusitis/bronEvidence of conditions that are known to cause chitis. She later developed bronchiectasis and destructive vasculitis has to be sought in every interview with the nasal granulomata in conjunction with a generalized patient. The patient's history should be thoroughly vasculitic syndrome that did not improve upon immunoscreened for drug hypersensitivity, infection (hepatitis!), suppression and antibiotics. A severe reduction of MHC rheumatic diseases (including rheumatoid arthritis, class I molecules at the cell surface of the B-cell lines systemic lupus erythematosus, Sjö gren's syndrome), was observed, whereas MHC class II expression was neoplastic disorders, and inflammatory bowel diseases. not altered. Isoelectric focusing of metabolically labelled Today's thinking about vasculitis is all too often MHC class I molecules revealed that class I heavy chains restricted to the group of primary vasculitides. Doctors remained unsialylated, consistent with a block of TAPare less willing to consider those secondary, e.g. to the dependent translocation. These conclusions were convarious conditions depicted in Table 8 . This is probably firmed by further experiments showing that peptide the reason why in the past year many reports in leading translocation was completely abolished. We also demonjournals have stated that infectious origins should always strated that presentation of viral antigens through endobe considered. Despite the progress that has been made genous class I molecules was severely impaired.
in the field of vasculitis within the past decade, this Immunoprecipitation and Western blotting of TAP1/2 group of diseases still poses a challenge to doctors and complex showed that TAP2 was not detectable [29] .
scientists today, and will continue to do so in the future. In our latest paper we reported five patients with the same genetic defect who displayed a remarkable homogeneity of clinical symptoms and disease course [30] . In this disease. Our findings illustrate the general principle 
